Keebeck Alpha, LP Seagen Inc. Transaction History

Keebeck Alpha, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$191.51 - $216.16 $392,212 - $442,695	2,048 Added 42.01%	6,923 $1.47 Million
Q2 2023 Jul 25, 2023	BUY	$187.64 - $206.25 $446,770 - $491,081	2,381 Added 95.47%	4,875 $938,000
Q1 2023 May 11, 2023	BUY	$127.59 - $203.08 $105,899 - $168,556	830 Added 49.88%	2,494 $504,000
Q3 2022 Nov 07, 2022	BUY	$135.27 - $180.11 $225,089 - $299,703	1,664 New	1,664 $228,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.